Page 2 - Carl Lindgren News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Carl lindgren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Carl Lindgren Today - Breaking & Trending Today

Karo Pharma divests brand portfolio to Evolan Pharma

Karo Pharma divests brand portfolio to Evolan Pharma
prnewswire.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.co.uk Daily Mail and Mail on Sunday newspapers.

Karo Pharma , Christoffer Lorenzen , Carl Lindgren , Vp Business Development , Evolan Pharma , Morfin Special , Nasdaq Stockholm Mid , கரோ பார்மா , கார்ல் லிண்ட்கிரென் , வ்ப் வணிக வளர்ச்சி , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் நடுவில் ,

Jämtlands bryggeri firar 25 år: "Förhoppningsvis kan vi ha någon festlighet till hösten"

Jämtlands bryggeri firar 25 år: "Förhoppningsvis kan vi ha någon festlighet till hösten"
ltz.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ltz.se Daily Mail and Mail on Sunday newspapers.

Carl Lindgren , Kjell Anderson , David Jones , First June , I Ve Sat , கார்ல் லிண்ட்கிரென் , டேவிட் ஜோன்ஸ் ,

Karo Pharma acquires European OTC brand portfolio from Teva Pharmaceuticals


Karo Pharma acquires European OTC brand portfolio from Teva Pharmaceuticals
News provided by
Share this article
Share this article
HUDDINGE, Sweden, Feb. 3, 2021 /PRNewswire/ Karo Pharma Aktiebolag ( Karo ) today announces the acquisition of an OTC brand portfolio containing Flux
®, Decubal
The transaction transfers ownership of the brand portfolio, comprised of Flux
®, Decubal
® and Fludent
® from Teva to Karo. The brands generated sales just short of EUR 35m in 2020 on a global basis. The majority is generated in the Nordic markets, including Scandinavia, where the brands already are distributed and marketed by Karo under a 7-year license agreement that was signed in the spring of 2019. ....

Karo Pharma , Christoffer Lorenzen , Carl Lindgren , Teva Pharmaceuticals , Vp Business Development , Pharma Aktiebolag , Nasdaq Stockholm Mid , கரோ பார்மா , கார்ல் லிண்ட்கிரென் , தேவா மருந்துகள் , வ்ப் வணிக வளர்ச்சி , நாஸ்டாக் ஸ்டாக்‌ஹோல்ம் நடுவில் ,